At The Baker Company, we not only share your passion for your work, but also the wider mission of most efficiently utilizing our limited natural resources.
That's why we are proud to introduce the SterilGARD e3, which offers a new standard in complete life protection-for you, your work and our environment. Make the world a better place.
president's /executive director's column 
S cott Becker:
When we talk about ef ciency-and there will be a lot of talk about this in the coming year-we are looking at both internal lab ef ciency and network ef ciencies. Some of these conversations are going to be dif cult, but it is imperative that we examine the hard realities and make decisions as fast as we possibly can. Change is going to happen, like it or not, and we are far better off leading the way than being shaped passively by the inevitable market or political forces.
Patrick Luedtke: It is time for lab leaders to look at the horizon and look at where we could be. There may be some nonUtopian vistas, but largely I think there are some reasonable solutions out there that have not been explored fully yet.
Becker: CDC has been talking about a "higher ef ciency lab system" for a while now. As this discussion evolves, clues to what that actually means are emerging. As funding shrinks, it makes sense to reward and support laboratory efforts to reduce costs and improve ef ciency through new partnerships, upgraded billing practices or quality improvement initiatives. The idea of shared services is in our future; better that we shape it than have it shape us.
We're even hearing of potential new budget initiatives still years away that may help us shape and innovate for greater ef ciencies.
Luedtke: Too often, we don't think of partnering with another lab until it becomes an obvious partner, when there is an oil spill or a waft of poison blowing toward your state.
We should be much more proactive developing shared sustainable programs, especially within specialized disciplines. Some call that "regionalization" and get scared, but given our current challenges-signi cant spending limits and political partisanshipwe're stuck with this milieu. We need to look internally and externally at getting better.
Becker: None of this is new or even unique to the US, which I hope allows us to approach this less fearfully. I went to a meeting of the Canadian Public Health
Laboratory Network-a much smaller network, about 20% our size-and they have many of the same issues despite their completely different funding structures and support mechanisms. They are also trying to improve service and become more ef cient. These are cross-cutting issues, shared by us all, wherever we are. I think the two big topics we need to talk about are 1) ef ciency, of all kinds, and 2) identifying new work.
Luedtke: I've been thinking about that Thomas Friedman book, The World Is Flat,
where he argues that due mainly to efcient technology, no one in the business world has the upper hand anymore. We can all compete equally wherever we are. Is the lab world at? Or can we atten it?
CREATING EFFICIENT LAB SYSTEMS AND GOING BEYOND OUR USUAL WORK by Pat Luedtke, President, APHL, and Scott Becker, Executive Director, APHL
Becker: Well, projects like PHLIP will help.
We could become atter if we could ensure data transmission across the network.
Luedtke:
We have terrible gaps in our healthcare IT, which makes all of this so much harder than it needs to be. I see a diabetic patient every two months for monitoring. Recently, after we discussed his progress, he asked, "What about the staples, doc?" In the two months since our last appointment, he had gone to the ER for back pain, received a cancer diagnosis, and then endured numerous surgeries, a 33-day hospital stay, radiation and other therapies. In all, there were 11 opportunities for those doctors to communicate with his primary care doctor-me-but not one had occurred. Likewise, my public health lab conducted two tests for this patient-H1N1
and Hepatitis-and neither result made it to his medical le. Health IT gaps like these leave our medical providers with no alternative but to practice defensive, and expensive, medicine.
Becker: And, I think, the lab's ability to communicate with healthcare providers is about to become even more important.
Lab leadership needs to decide how we can impact chronic disease. To be frank, high sodium levels kill more people than foodborne outbreaks. Why shouldn't this type of testing be in our realm? Our job is to improve public health.
Luedtke: This could mean nutritional testing on our kids' school lunches, glucose monitoring for diabetics, imported drug testing or improved food safety testing programs.
Becker: What do labs do? We measure stuff. The difference between clinical, public health and environmental lab work is why we are measuring stuff. Tackling the biggest public health problems of our day-for example, obesity, its causes, its rami cations-makes sense.
Luedtke: Expanding our focus especially makes sense when we are simultaneously talking about streamlining our overlapping areas. I've given a lot of thought to what I call the "small state syndrome." We all have unique structural challenges, but small states have fewer quali ed job applicants, fewer vendor options at higher costs, and smaller university systems to partner with.
We also have small testing volumes, which make it dif cult to compete for grants and maintain expertise, and our bulk purchasing is more expensive-the Texas State Lab pays 29 cents apiece for blood agar plates while we pay 91 cents. We need to identify our logical partners and gure out how to get this done.
Becker:
We're not talking about shrinking down to 20 regionalized labs, or any arbitrary number like that. That is not what this is about. We will continue our advocacy for all labs. But we need to provide value with our programs… and these issues cross over into moderate and large labs too.
Luedtke:
As it stands, we already don't do it all on our own. We all share a goal for public health. Does everything have to happen in your space?
Becker: We need to continue to advocate for preparedness, for response, for all of the important testing that occurs in public health labs, but also be realistic with our scal responsibilities and team up to make good decisions that will bene t us all.
Luedtke: Labs should also be evaluating internal ef ciencies. This can yield enormous bene t. After a Lean Six Sigma evaluation at the Louisiana State Crime Lab, they saw a 400% improvement, increasing their output from two to eight cases per day.
Becker: All of this, this entire discussion, belongs in our sphere. But it has become such a pressing issue, so quickly, that it is being talked about at all levels of the public health system. I think it is imperative that we take leadership of this discussion and make certain that the right decisions are made, whether we're talking about vaccine-preventable disease, tuberculosis, HIV, emergency response or other testing programs.
We need to look to existing regional models-such as Washington state's radiation program and its role after Japan's nuclear disaster-and identify geographic or population issues.
Becker: Recently, an editorial in the American Journal of Public Health advised trans-
forming the public health mindset from victim to victor by taking charge and being accountable. Creating new ef ciencies in our lab system is something that we can and should do to meet our responsibilities to the public. The editorial also recommended a bold commitment to lofty goals, which is also something to keep in mind as we discuss our proper role in chronic disease prevention.
Luedtke: When something isn't working, it might be time to try something else. It's time to partner with other labs and to weigh the value of our services in addressing our communities' greatest health needs.
Becker: I hope many of you are able to join this discussion at APHL's Annual Meeting in June.
environmental health O n March 11, 2011, a 9.0 magnitude earthquake in northwest Japan triggered a string of events that endangered the Japanese and put the US on high alert.
The subsequent tsunami caused ooding, a series of explosions and the destabilization of the Fukushima Nuclear Power Plant in Japan, releasing radiation into the environment.
Within the week, US federal agencies activated emergency response mechanisms to support Japanese efforts and prevent any potentially harmful effects of fallout in the US. The FDA issued an import alert against certain foods from restricted areas of Japan and activated the Food Emergency Response Network (FERN) in the event it became necessary to test the US food supply for radiation contamination.
CDC also activated its Emergency Operations Center (EOC) to provide assistance during the response. 
ROLE OF APHL

WHAT IS HAPPENING?
EPA, state radiation control program directors, and some public health laboratories-including Washington State-monitor air, ground water, drinking water, precipitation and milk for radiation on a routine basis. Since this event, sampling frequency has increased and several states have reported Iodine-131 in air, precipitation and milk samples.
However, none of the levels are actionable or a cause for public health concern. Even more reassuring, the levels appear to decrease slightly with each sample set, in all the matrices being monitored.
AT THE FEDERAL LEVEL:
EPA continues collecting data from the RadNet network, which includes air, lter, water and milk samples. The frequency of sampling was increased for some of these sample types.
The public can access all of the EPA data at http://epa.gov/japan2011.
FDA increased the monitoring of domestic and imported foods, and medical devices and supplies, mostly using the capacity available at 
REAL-WORLD EXAMPLES
MEMBER HIGHLIGHTS
The North Carolina State Laboratory of Public Health received funds to implement both MLVA and molecular serotyping. After implementing MLVA procedures, the facility now performs MLVA analysis on all E coli O157:H7 upon receipt of culture in its pulsed-field gel electrophoresis (PFGE) laboratory. For Salmonella serotyping, the laboratory received funding to purchase reagents and consumables, as well as an upgrade for the Bio-Rad BioPlex software. Upon implementation of this assay, the lab will be able to determine Salmonella serotypes with 24-48 hours of isolation.
The Massachusetts PFGE laboratory at the William A. Hinton State Laboratory Institute received a portion of the 2010 IMS grant. The grant was essential for the laboratory to order both IMS and MLVA reagents. As a result, Massachusetts will be able to validate IMS testing for E. coli in the enteric laboratory and incorporate MLVA into the PFGE laboratory.
Luminex scientists work on assay using LX System. Screening for these diseases would be bene cial for early treatment and improved long-term health outcomes. 
EXPANDING THE NEWBORN SCREENING FRAMEWORK TO IDENTIFY OTHER GENETIC DISORDERS
APHL TASKFORCE ADDRESSES THE INTEGRATION OF GENETICS INTO NEWBORN SCREENING by Elizabeth Jones, specialist, newborn screening and genetics
The GED DI project takes a life-stage approach:
screening and identifying individuals before the age of typical disease onset, thus enabling treatment before symptoms or disability occurs. This framework helps educate families about unknown health risks. GEDDI will focus on developing guidance for rare genetic disorders that have substantial amounts of scienti c evidence, and then expand to more common diseases. "Too often, we miss opportunities to achieve early diagnosis, and reduce the diagnostic odyssey for many patients with genetic conditions.
Using a multidisciplinary, systems-based approach, the GEDDI project works to support the establishment of new paradigms for screening and to integrate these approaches into public health and clinical care," stated Amanda Field, public health programs manager at Genetic Alliance. 
MOVING LABS TOWARD INTEROPERABILITY ELECTRONIC LABORATORY SURVEILLANCE MESSAGE (ELSM) FOR INFLUENZA
Since March 2010, this initiative has deployed two technical PHLIP Assistance Teams (PATs) to bolster in-house laboratory messaging capabilities within the state laboratories with virtual or hands-on support.
To date, the PATs have visited 26 public health laboratories (PHLs) and will visit at least seven more through August 2011. Personnel from the CDC In uenza Division have participated in some of the visits to strengthen partnerships with the laboratorians.
The PHLIP ELSM message is in its third in uenza season with 24 public health laboratories sending production seasonal and novel in uenza data to the CDC, and another 24 labs working on implementation.
PHLIP -ELECTRONIC TEST ORDER AND RESULT (ETOR) FOR INFLUENZA
The PHLIP ETOR message for in uenza has been tested successfully among ve public health laboratories for surge capacity and mutual assistance. These states now have the ability to assist each other with testing during natural disasters or outbreak surges. 
PHLIP -ELECTRONIC TEST ORDER AND RESULT (ETOR) FOR SALMONELLA
PHLIP -VOCABULARY HARMONIZATION
WHAT'S NEXT?
More states are slated to send the PHLIP ELSM for in uenza format over the next months, giving the CDC In uenza Division a more accurate picture of disease trending. Other divisions within CDC have also expressed interest in the PHLIP methodologies.
Due to this initiative's knowledge base and its exibility to expand, health care entities outside of the PHL realm may be turning to PHLIP for further direction as "meaningful use" guidelines spread the demand for national electronic data-sharing networks.
Fair Winds for the Future
Save the Date! November 7-10, 2011 www.aphl.org 
A DECLINE IN QUALITY?
Michel, who originally trained as an economist, said, "When you have a shortage of something, two things happen: you substitute for it or people pay a higher price to meet the demand."
In the healthcare arena, however, there is pressure to ratchet down the cost of labo- Even if federal and state governments take action to address the gathering crisis, it will take time to get CLS programs restarted and accredited and to recruit and graduate students. "You can't change this whole daisy chain overnight," said Forsman.
In the meantime, understaf ng has already had an effect on PHL emergency holmesii from B. pertussis will be of great bene t to our local public health departments and allow them to eliminate unnecessary follow-up and inappropriate patient management for cases of B. holmesii.
MEASLES IgM SEROLOGY PT-LIKE EXERCISE
BORDETELLA PCR PT-LIKE EXERCISE
The CDC protocol will help us determine the incidence of B. holmesii in our population and, hopefully, help better de ne its role in respiratory disease."
WHAT'S NEXT?
Choosing 
CURRENT TESTING PRACTICES
Under budget cuts, PHLs cannot retain the capability to test for all disease agents.
In fact, most PHLs already do not. Also, for much VPD testing, the availability of commercial assays is declining, which increases the reliance on the laboratorydeveloped tests used by a handful of facilities. In response, PHLs have had to come up with different solutions to maintain testing capabilities, most often informal "shared services" testing agreements among neighboring state PHLs; or PHLs may simply count on CDC to perform testing.
LABORATORY CAPACITY MODELS -DOES THIS MEAN "REGIONALIZATION"?
The and so forth. Therefore, the method is intended to be a template that a laboratory can customize to its own unique accounting requirements and organizational structure. As examples, laboratory-speci c cost data regarding labor, consumables, and indirect costs can be captured using this tool.
Each laboratory will eventually have its own URL to access the SharePoint site, thereby protecting condentiality of the data. In the future, as the tool is used by states, APHL can better explore trends seen in the data. An overview to the tool will be given in late June 2011 via a web conference.
For more information on the cost accounting tool and to obtain access to its SharePoint site, contact Tina Su at bertina.su@aphl.org.
There has been consensus that laboratories need a consistent framework
and standard method upon which to estimate costs. No one can predict the next radiological incident to occur in the US, so it is always prudent to prepare for any emergency no matter how rare or unlikely. At CDC, we continue to prepare to respond to different types of public health emergencies, including radiological or nuclear threats.
NEW COST ACCOUNTING TOOL CAPTURES LAB EXPENSE
Q2. IN 2007, THE UK POLONIUM-210 EVENT SPARKED AN INCREASE IN AWARENESS OF RADIATION EXPOSURE AND BROUGHT IT TO THE FOREFRONT FOR NEEDED IMPROVEMENTS IN HUMAN EXPOSURE RADIATION TESTING CAPABILITIES, WHAT HAVE THE EVENTS IN JAPAN BROUGHT TO THE FOREFRONT OF OTHER TESTING CAPABILITIES?
The Japan incident has shown the value of 
Q3. ARE US LABS PREPARED FOR A DOMESTIC RAD EVENT, AND WHAT MUST PUBLIC HEALTH LABORATORIES DO IN ORDER TO BE BETTER PREPARED?
Many of the public health and environmental laboratories are experienced in testing for radionuclides in environmental samples such as water, soil, and plant mate- 
Q5. WHAT CAN BE DONE TO ENHANCE LABORATORY CAPACITY AND CAPABILITY TO TEST ALL SAMPLE TYPES (HUMANS, ANIMALS, FOOD, ENVIRONMENTAL (AIR, WATER, SOIL) AND OTHER NON-CLINICAL SAMPLES) FOR A RADIOACTIVE RESPONSE?
The federal government, notably the EPA and the FDA, is currently working to increase 
Q7. ANYTHING ELSE YOU'D LIKE TO SHARE WITH OUR READERS?
APHL members, and really, anyone, can respond best to emergencies when they are Finalists for the next class of EID laboratory fellows will be interviewed in June.
APHL looks forward to placing this 17th class of fellows. 
APHL'S ENVIRONMENTAL HEALTH FELLOWS
FACILITY
The public health laboratory is in the city are also endemic; however, HSLD has yet to obtain funding to establish testing for these diseases so specimens must be sent to CDC.
KEEPING BEAUTIFUL SAN MATEO HEALTHY
In addition to the 60,000 clinical tests performed annually, HSLD also provides environmental testing for state programs.
In a typical year, the HSLD tests 650,000 air Unfortunately, the couple thousand miles of ocean separating Hawaii from the nearest continent has not been enough to insulate "paradise" from the nancial crisis that rocked much of the world.
FINANCIAL CRISIS TAKES A TOLL
Hawaii's #1 industry is tourism, and fewer visitors means less state revenue.
Although there are signs tourism is rebounding, dif cult times are still ahead.
Analysts project a $1.3 billion shortfall for the 2012-13 budget cycle, and Hawaii has a balanced budget law.
WHAT DOES THIS MEAN FOR THE HSLD?
State funding to the laboratory is $5. 
GEN-PROBE TRICHOMONAS ASSAY FDA-CLEARED
by H. Peter Kelley, director of National Accounts, Gen-Probe
DIAMOND PARTNERS
PLATINUM PARTNERS GOLD PARTNERS APHL SUSTAINING MEMBER PROGRAM
The following corporations partner with APHL to support the nation's public health laboratory system. 
